Sign Up Today and Learn More About Merck Stock

Invest in or calculate the value of your shares in Merck or other pre-IPO companies through EquityZen's platform.

Get Started

Merck Stock

Merck is a healthcare, life science company.

About Merck Stock

Founded

1967

Industries

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 56,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene- editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2018, Merck generated sales of €14.8 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Merck was incorporated in India as E. Merck India Private Limited in 1967. In 2017 they completed 50 years in India, starting out as a pharmaceutical company and growing to become a science and technology business spanning all the sectors of Healthcare, Life Science and Performance Materials. In India Merck has offices, manufacturing sites and IT centres across Mumbai and Bengaluru. Sales offices are located in Delhi, Kolkatta and Hyderabad. Over 2000 employees represent Merck in India.
Locked Features

Join now and verify your accreditation status to gain access to:

  • Merck current valuation
  • Merck stock price
  • Available deals in Merck and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Merck stock?

Accredited investors can buy pre-IPO stock in companies like Merck through EquityZen funds. These investments are made available by existing Merck shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Merck stock?

Shareholders can sell their Merck stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."